A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT01057407
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT01057407
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01057407. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2010-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
- Condition
- Chronic Kidney Disease
- Condition
- Renal Dialysis
- Condition
- Renal Insufficiency
- Intervention (Drug)
- ASP1585
- Intervention (Drug)
- Sevelamer hydrochloride
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01057407- Content hash
b8db4cc225e15d0ecddd5555ceef7b2c36f57254d33af22b82d9a7e2468a1ea3